相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
C. Romei et al.
CLINICAL ENDOCRINOLOGY (2011)
Risk Profiles and Penetrance Estimations in Multiple Endocrine Neoplasia Type 2A Caused by Germline RET Mutations Located in Exon 10
Karin Frank-Raue et al.
HUMAN MUTATION (2011)
A Cys634Gly substitution of the RET proto-oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis
Marco Seri et al.
CLINICAL GENETICS (2010)
Frequent Gastrointestinal Polyps and Colorectal Adenocarcinomas in a Prospective Series of PTEN Mutation Carriers
Brandie Heald et al.
GASTROENTEROLOGY (2010)
Pathogenicity of DNA Variants and Double Mutations in Multiple Endocrine Neoplasia Type 2 and Von Hippel-Lindau Syndrome
Zoran Erlic et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
Samuel A. Wells et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Diffuse ganglioneuromatosis in small intestine associated with neurofibromatosis type 1
Khin Thway et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2009)
Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Patients
Zoran Erlic et al.
CLINICAL CANCER RESEARCH (2009)
PTEN hamartoma tumor syndrome: An overview
Judith A. Hobert et al.
GENETICS IN MEDICINE (2009)
Multiple Endocrine Neoplasia Type 2 RET Protooncogene Database: Repository of MEN2-Associated RET Sequence Variation and Reference for Genotype/Phenotype Correlations
Rebecca L. Margraf et al.
HUMAN MUTATION (2009)
Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2
Carsten C. Boedeker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Clinical Features of Paraganglioma Syndromes
Carsten Christof Boedeker et al.
SKULL BASE-AN INTERDISCIPLINARY APPROACH (2009)
One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: Is this a new syndrome-MEN 2C?
Alexander L. Shifrin et al.
SURGERY (2009)
Familial Medullary Thyroid Carcinoma Associated with Cutaneous Lichen Amyloidosis
Amy E. Rothberg et al.
THYROID (2009)
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Richard T. Kloos et al.
THYROID (2009)
Comparison of 6-18 F-Fluorodopamine PET with 123I-Metaiodobenzylguanidine and 111In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic Pheochromocytoma
Ioannis Ilias et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Recurrent or Residual Hyperparathyroidism and Thyroid Cancer Effectively Evaluated with Scintigraphy
Michele E. Brenner et al.
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA (2008)
Pheochromocytoma in MEN 2A Syndrome. Study of 54 Patients
Jose M. Rodriguez et al.
WORLD JOURNAL OF SURGERY (2008)
Failure to recognize multiple endocrine neoplasia 2B: More common than we think?
Curtis J. Wray et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
RET genetic screening in patients with medullary thyroid cancer and their relatives:: Experience with 807 individuals at one center
Rossella Elisei et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules
Giuseppe Costante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Adverse drug reactions in patients with phaeochromocytoma - Incidence, prevention and management
Graeme Eisenhofer et al.
DRUG SAFETY (2007)
Cancer phenomics: RET and PTEN as illustrative models
Kevin M. Zbuk et al.
NATURE REVIEWS CANCER (2007)
Phaeochromocytoma, new genes and screening strategies
Anne-Paule Gimenez-Roqueplo et al.
CLINICAL ENDOCRINOLOGY (2006)
RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B
Aaron N. Cranston et al.
CANCER RESEARCH (2006)
Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma
Birke Bausch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Multiple endocrine neoplasia type 2 and the RET protooncogene: From bedside to bench to bedside
A Machens et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
The familial medullary thyroid carcinoma-associated RET E768D mutation in a multiple endocrine neoplasia type 2A case
A Aiello et al.
SURGERY (2005)
Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour
K Pacak et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Diagnosis and management of medullary thyroid carcinoma
N Massoll et al.
CLINICS IN LABORATORY MEDICINE (2004)
Minireview: RET: Normal and abnormal functions
M Santoro et al.
ENDOCRINOLOGY (2004)
Germline RET V804M mutation associated with multiple endocrine neoplasia type 2A
H Gibelin et al.
BRITISH JOURNAL OF SURGERY (2004)
Early malignant progression of hereditary medullary thyroid cancer
A Machens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Pheochromocytoma: The expanding genetic differential diagnosis
J Bryant et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Frequent association between MEN 2A and cutaneous lichen amyloidosis
U Verga et al.
CLINICAL ENDOCRINOLOGY (2003)
American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility
SS Bruinooge
JOURNAL OF CLINICAL ONCOLOGY (2003)
RET codon 634 mutations in multiple endocrine neoplasia type 2:: Variable clinical features and clinical outcome
MK Puñales et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Surgical treatment of medullary thyroid carcinoma
MS Cohen et al.
JOURNAL OF INTERNAL MEDICINE (2003)
Acceptable age for prophylactic surgery in children with multiple endocrine neoplasia type 2a
T Kahraman et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2003)
Review of multiple endocrine neoplasia type 2A in children: Therapeutic results of early thyroidectomy and prognostic value of codon analysis
G Szinnai et al.
PEDIATRICS (2003)
Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation
M Brauckhoff et al.
THYROID (2002)
Germ-line mutations in nonsyndromic pheochromocytoma.
HPH Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
V804M RET mutation and familial medullary thyroid carcinoma:: Report of a large family with expression of the disease only in the homozygous gene carriers
A Lecube et al.
SURGERY (2002)
Multigenerational familial medullary thyroid cancer (FMTC): evidence for FMTC phenocopies and association with papillary thyroid cancer
L Fugazzola et al.
CLINICAL ENDOCRINOLOGY (2002)
RET activation and clinicopathologic features in poorly differentiated thyroid tumors
M Santoro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Guidelines for diagnosis and therapy of MEN type 1 and type 2
ML Brandi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
The RET receptor:: function in development and dysfunction in congenital malformation
S Manié et al.
TRENDS IN GENETICS (2001)
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma
D Astuti et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Genotype-phenotype correlations in hereditary medullary thyroid carcinoma:: Oncological features and biochemical properties
A Machens et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study
L Nguyen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)
Multiple endocrine neoplasia type 2B - genetic basis and clinical expression
NC Lee et al.
SURGICAL ONCOLOGY-OXFORD (2000)
Multiple endocrine neoplasia type 2 and RET:: from neoplasia to neurogenesis
JR Hansford et al.
JOURNAL OF MEDICAL GENETICS (2000)
The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease
MC Bordeaux et al.
EMBO JOURNAL (2000)
Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG→ATG) mutation
GL Feldman et al.
SURGERY (2000)
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
BE Baysal et al.
SCIENCE (2000)
分享论文
